We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 of my best ever dividend stocks: GlaxoSmithKline plc, Aviva plc and Royal Mail plc

These three stocks have superb income potential: GlaxoSmithKline plc (LON: GSK), Aviva plc (LON: AV) and Royal Mail plc (LON: RMG).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

However quickly interest rates rise, the yields on offer at the present time are hugely enticing by historical standards. In fact, it’s not just the yields that should be getting income-seeking investors excited, but also the prospects for rapid dividend rises. Here are three stocks that offer both of those attributes right now.

GlaxoSmithKline

With a yield of 5.6%, GlaxoSmithKline (LSE: GSK) remains one of the highest yielding stocks in the FTSE 100. While its dividends are set to flatline over the next couple of years as it seeks to strengthen its financial position and raise its dividend coverage ratio, in the long run GlaxoSmithKline seems likely to increase shareholder payouts at a generous rate.

XXX

A key reason for this is the company’s long-term earnings growth prospects. GlaxoSmithKline has one of the most impressive drug pipelines in the pharmaceutical business, with it being well-diversified as well as large so as to reduce the risk of disappointment from worse-than-expected drug trial performance. This means that GlaxoSmithKline is likely to raise dividends at a rapid rate in future years, which alongside a high yield and a diversified business model equates to a top-notch income play.

Aviva

Like GlaxoSmithKline, Aviva (LSE: AV) has an excellent yield that holds vast appeal even if interest rates rise at a brisk pace. Aviva currently yields 5.5% and while this is high, it’s likely to become even more enticing for the company’s investors as Aviva’s integration with Friends Life continues.

The combined company could dominate the life insurance market over the coming years and with the synergies from the deal, Aviva appears to be in a strong position to raise dividends over the medium term. In fact, as soon as next year Aviva is forecast to increase the amount it pays out to shareholders by 10.6% and such a rate of growth may not be surprising in future years too.

That’s because Aviva currently pays out just half of profit as a dividend and while some funds are required for reinvestment, Aviva could become more generous when it comes to dividends and boost shareholder payouts at a faster rate than profit growth.

Royal Mail

Royal Mail (LSE: RMG) continues to be a company of two halves. While its UK letters business is a rather disappointing division, its European segment is a growth driver that should allow the company to raise dividends in future years. As soon as next year Royal Mail is expected to increase shareholder payouts by 5.2% and even with that pace of rise the company’s payouts are still set to be covered 1.8 times by profit. This indicates that further growth is very much on the cards.

Allied to an upbeat dividend outlook is a yield of 4.3%, which is around 10% higher than the FTSE 100’s yield. And with Royal Mail having a price-to-earnings (P/E) ratio of just 12.5, it appears to offer excellent value for money as well as strong income potential.

Peter Stephens owns shares of Aviva, GlaxoSmithKline, and Royal Mail. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »